In the ever-evolving GLP-1 market landscape, OPTAVIA provides support to meet the needs of customers in all stages of their health journey, including those utilizing GLP-1 medications.
Most patients notice early shifts in inflammation, gut comfort and pain within 1 to 3 weeks
Every patient is monitored by licensed professionals with lab checks, vitals tracking, and dose adjustments to make sure your journey is safe, effective, and personalized
Eligibility is primarily based on BMI, though this is not the only consideration
This addresses a longstanding problem: Part D did not originally have a true out-of-pocket maximum enrollees with very high drug costs (for instance, expensive cancer medications or multiple brand-name drugs for chronic diseases) could end up spending thousands per year even after reaching the catastrophic phase, since they kept paying 5% coinsurance on each refill with no limit